BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33464405)

  • 21. Clinical Case Panel: Treatment Alternatives for Inoperable Hepatocellular Carcinoma.
    Toesca DAS; Barry A; Sapisochin G; Beecroft R; Dawson L; Owen D; Mouli S; Lewandowski R; Salem R; Chang DT
    Semin Radiat Oncol; 2018 Oct; 28(4):295-308. PubMed ID: 30309640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
    Au JS; Frenette CT
    Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
    Han K; Kim JH; Ko GY; Gwon DI; Sung KB
    World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen.
    Kim YS; Rhim H; Lim HK; Park CK; Lee WJ; Do YS; Cho JW
    J Comput Assist Tomogr; 2006; 30(4):578-82. PubMed ID: 16845287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
    Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging Hepatocellular Carcinoma with Dynamic CT Before and After Transarterial Chemoembolization: Optimal Scan Timing of Arterial Phase.
    Saake M; Lell MM; Eller A; Wuest W; Heinz M; Uder M; Schmid A
    Acad Radiol; 2015 Dec; 22(12):1516-21. PubMed ID: 26411380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
    Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
    J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept.
    Abajian A; Murali N; Savic LJ; Laage-Gaupp FM; Nezami N; Duncan JS; Schlachter T; Lin M; Geschwind JF; Chapiro J
    J Vasc Interv Radiol; 2018 Jun; 29(6):850-857.e1. PubMed ID: 29548875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: initial results.
    Cascales Campos P; Ramirez P; Gonzalez R; Febrero B; Pons JA; Miras M; Sanchez Bueno F; Robles R; Parrilla P
    Transplant Proc; 2011; 43(6):2213-5. PubMed ID: 21839236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
    Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP
    J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bridging to liver transplantation in HCC patients.
    Kollmann D; Selzner N; Selzner M
    Langenbecks Arch Surg; 2017 Sep; 402(6):863-871. PubMed ID: 28755240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
    Liu D; Liu M; Su L; Wang Y; Zhang X; Long H; Kuang M; Xie X; Lin M
    J Vasc Interv Radiol; 2019 Dec; 30(12):1879-1886. PubMed ID: 31669087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
    Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
    World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma (HCC): an update.
    Rougier P; Mitry E; Barbare JC; Taieb J
    Semin Oncol; 2007 Apr; 34(2 Suppl 1):S12-20. PubMed ID: 17449346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of hepatocellular in the United States.
    Mokdad AA; Hester CA; Singal AG; Yopp AC
    Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?
    Hui TC; Pua U
    J Vasc Interv Radiol; 2014 Jan; 25(1):41-6. PubMed ID: 24290098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.